Ingevity Corporation
NGVT
$59.47
-$0.04-0.07%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -0.21% | 12.36% | -16.50% | -19.61% | -25.16% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -0.21% | 12.36% | -16.50% | -19.61% | -25.16% |
| Cost of Revenue | -1.48% | 30.70% | -29.03% | -34.82% | -36.21% |
| Gross Profit | 1.75% | -5.39% | 13.74% | 36.44% | 2.02% |
| SG&A Expenses | 16.36% | 23.26% | -8.69% | -10.07% | -5.25% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.62% | 29.43% | -24.92% | -30.91% | -32.48% |
| Operating Income | -5.37% | -17.95% | 38.50% | 116.90% | 7.76% |
| Income Before Tax | 15.19% | 14.31% | 137.27% | 105.71% | 68.22% |
| Income Tax Expenses | 229.23% | 150.00% | 139.62% | 79.03% | -5.80% |
| Earnings from Continuing Operations | -14.11% | -0.23% | 136.61% | 114.21% | 88.49% |
| Earnings from Discontinued Operations | 101.75% | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 140.58% | 48.36% | 136.61% | 114.21% | -525.40% |
| EBIT | -5.37% | -17.95% | 38.50% | 116.90% | 7.76% |
| EBITDA | -4.66% | -17.30% | 13.77% | 59.56% | 1.70% |
| EPS Basic | 140.62% | 48.51% | 136.49% | 114.17% | -523.96% |
| Normalized Basic EPS | -1.28% | -40.93% | 1,357.25% | 447.62% | 12.56% |
| EPS Diluted | 139.91% | 48.55% | 136.26% | 114.04% | -525.97% |
| Normalized Diluted EPS | -2.61% | -40.62% | 1,347.64% | 443.13% | 12.61% |
| Average Basic Shares Outstanding | -0.10% | 0.33% | 0.33% | 0.28% | 0.33% |
| Average Diluted Shares Outstanding | 1.27% | 0.33% | 1.10% | 1.10% | 0.29% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |